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Abstract.  Lipoprotein lipase (LPL) and glycolipid- 
anchored cAMP-binding ectoprotein (Gcel) are 
modified by glycosyl-phosphatidylinositol (GPI) in rat 
adipocytes, however, the linkage is potentially unsta- 
ble. Incubation of the cells with either insulin (0.1-30 
nM) or the sulfonylurea, glimepiride (0.5-20/zM),  in 
the presence of glucose led to conversion of up to 35 
and 20%, respectively, of the total amphiphilic  LPL 
and Gcel to their hydrophilic versions.  Inositol-phos- 
phate was retained in the residual protein-linked an- 
chor structure.  This suggests cleavage of the GPI an- 
chors by an endogenous GPI-specific insulin- and 
glimepiride-inducible phospholipase (GPI-PL).  De- 
spite cleavage, hydrophilic LPL and Creel remained 
membrane associated and were released only if a com- 
petitor, e.g., inositol-(cyclic)monophosphate, had been 
added.  Other constituents of the GPI anchor (glucos- 
amine and mannose) were less efficient. This suggests 
peripheral  interaction of lipolytically cleaved LPL and 
Gcel with the adipocyte cell surface involving the ter- 
minal  inositol-(cyclic)monophosphate epitope and pre- 
sumably a receptor of the adipocyte plasma mem- 
brane.  In rat adipocytes which were resistant toward 
glucose transport stimulation by insulin,  the sensitivity 
and responsiveness of GPI-PL to stimulation by insu- 
lin was drastically reduced.  In contrast,  activation of 
both GPI-PL and glucose transport by the sul- 
fonylurea, glimepiride,  was not affected significantly. 
Inhibition of glucose transport or incubation of rat 
adipocytes in glucose-free medium completely abol- 
ished stimulation of GPI-PL by either insulin or 
glimepiride.  The activation was partially restored by 
the addition of glucose or nonmetabolizable 2-deoxy- 
glucose. These data suggest that increased glucose 
transport stimulates a  GPI-PL in rat adipocytes. 
reat body of information  exists regarding  the struc- 
tural diversity as well as the biosynthesis and post- 
translational  attachment  of glycosyl-phosphatidyl- 
inositol  (GPI)  ~ structures  (for  recent  reviews  see  Low, 
1989;  McConville et al.,  1993).  However,  the functional 
significance  of membrane  anchorage  via  GPI  structures 
versus transmembrane polypeptide domains is still a matter 
of debate. The accessibility of GPI molecules to cleavage by 
phospholipase [(G)PI-PL] opens the possibility of a regu- 
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proteins which have been synthesized  with a GPI membrane anchor ir- 
respective of whether this moiety is preserved or cleaved; LDM, low den- 
sity microsomes; LPL,  lipoprotein lipase; TX-114,  Triton X-114; VSG, 
variant surface glycoprotein. 
lated  release of the polypeptide portion of proteins which 
have been synthesized  with a GPI membrane anchor (GPI- 
proteins) from the cell surface (for a review see Low and Sal- 
tiel,  1988; Cross,  1990).  Experimental evidence has been 
presented that the released protein may exhibit altered func- 
tional characteristics  (e.g., Miiller and Bandlow, 1994) and/ 
or, in the case of multicellular  organisms,  may fulfill a spe- 
cial physiological  role at its new location (e.g., Smith  and 
Pownall,  1984). 
Whereas the number of studies on constitutive  membrane 
release of GPI-proteins is steadily increasing (e.g., Almqvist 
and Carlsson, 1988; Furley et al., 1990; Hortsch and Good- 
man, 1990), only limited experimental  evidence is available 
for regulated release so far. In a rat hepatocyte cell line it has 
been demonstrated that the linkage between the protein moi- 
ety of heparin  sulfate  proteoglycan and its GPI anchor is 
cleaved by an insulin-activated  PLC (Ishihara  et al., 1987). 
Short-term  incubation  of 3T3-L1 adipocytes  and  BC3HI 
myocytes with insulin or fetal serum causes release of some 
GPI-anchored ectoproteins.  Among the proteins  liberated 
from the cell surface into the culture medium are lipoprotein 
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line phosphatase (Romero et al.,  1988),  and a set of addi- 
tional unidentified GPI-proteins (Lisanti et al., 1989). In the 
case of LPL, retention of radiolabeled myo-inositol in the 
released molecules suggested lipolytic cleavage of the GPI 
moiety in response to insulin (Chan et al., 1988).  Further- 
more, treatment of isolated rat diaphragm with insulin leads 
to a decreased plasma membrane-associated 5'-nucleotidase 
activity which has been interpreted as an insulin-induced re- 
lease of the GPI-modified isoform of this enzyme from the 
plasma membrane (Klip et al.,  1988).  These observations 
have been interpreted in terms of a mechanistic coupling and 
direct signaling between the insulin (growth factor) recep- 
tors and GPI-PUs in mammalian cells. Finally, it has been 
demonstrated recently that glimepiride, a novel sulfonylurea 
drug (Geisen,  1988) which stimulates glucose transport in 
insulin-sensitive  isolated  and  cultured  cells  (Miiller  and 
Wied, 1993),  induces lipolytic cleavage of the GPI anchors 
of LPL, 5'-nucleotidase and a  cAMP-binding ectoprotein 
(Gcel),  in  cultured  3T3  adipocytes  in  a  concentration- 
dependent manner (Mtiller et al., 1993). In parallel to these 
observations with vertebrate cells, it has been described with 
lower eukaryotes that a  nutritional upshift of spheroplasts 
from the yeast Saccharomyces cerevisiae from lactate to glu- 
cose medium activates a GPI-PLC which cleaves the GPI 
anchor of a  cAMP-binding ectoprotein dependent on the 
concentration of  glucose (MiUler and Bandlow, 1993). These 
data suggest the existence of similar signaling cascades for 
the activation of GPI-PLs in lower eukaryotes and mam- 
malian cells with multiple entry sites for hormonal, drug- 
induced, or nutritional signals. 
In an attempt to elucidate the molecular mechanism which 
links these various signals to the lipolytic cleavage of certain 
GPI-proteins,  we first studied whether isolated rat adipo- 
cytes, which are characterized by exquisite sensitivity and 
responsiveness  toward  hormones  (like  insulin),  certain 
drugs (like sulfonylureas), and the nutritional situation, can 
be used as a model system for regulated GPI-protein release. 
We found that the GPI anchors of  two GPI-proteins, LPL and 
the  cAMP-binding  ectoprotein,  Gcel,  are  cleaved  by  a 
GPI-PL after stimulation of glucose transport by insulin and 
glimepiride which seems to funnel a signaling cascade lead- 
ing to activation of the GPI-PL. 
Materials and Methods 
Materials 
Affinity-purified  12SI-labeled anti-rabbit IgG from sheep and AMPLIFY 
were  obtained from Amersham-Buchler (Braunschweig,  Germany); re- 
agents for cell culture were obtained from GIBCO BRL (Eggenstein-Leo- 
poldshafen, Germany); protein A-Sepharose CL-4B was purchased from 
LKB/Pharmacia (Freiburg,  Germany); 2-deoxyglucose,  cytochalasin B, 
phloretin, and polymyxin B were bought from Sigma (Deisenhofen, Ger- 
many); protease inhibitors were bought from Boehringer Mannheim  GmbH 
(Mannheim, Germany); partially purified PI-PLC (Bacillus thuringiensis) 
was delivered by Biotrend (K61n, Germany); recombinant human insulin 
and glimepiride (HOE 490) were prepared by the synthesis depa_mnent of 
Hoechst AG (Frankfurt a.M., Germany); male Wistar rats were bred and 
delivered by Hoechst AG (Tierzucht Kastengrund, Germany); affinity-puri- 
fied polyclonal anti-glucose transporter isoform 4 (GLUT4) antibodies were 
obtained from rabbits injected with a peptide corresponding to the COOH- 
terminal 16 amino acids of rat GLUT4 and coupled to keyhole limpet hemo- 
cyanin; all other radiochemicals, chemicals, and antibodies were obtained 
as described previously  (Miiller et al.,  1993; MOiler and Wied,  1993). 
Primary Culture of  Adipocytes 
Freshly prepared adipocytes  were washed twice by flotation with 10 vol of 
I-IBSS (Marshall et al.,  1991) containing 25 U/ml penicillin and 50 t~g/ml 
streptomycin.  After the final wash,  1 ml of suspension (2  ×  105 cells/ml) 
was added to 3 rnl of HBSS containing 5 mM glucose (control) or 25 mM 
glucose,  10 nM insulin, 16 mM glutamine (for desensitization of the glu- 
cose transport system) and incubated (20 h, 37°C) in sterile 50-ml polysty- 
rene tubes as described (Traxinger and Marshall, 1989). After incubation, 
control and desensitized adipocytes  were washed by flotation,  twice with 
40 ml of HBSS containing 0.5% BSA and two times with 4 ml of DMEM 
containing 0.5 mM glucose,  1% BSA, 2% fetal calf serum, and 25 mM 
Hepes (pH 7.4). Then the cells were suspended at 0.5  ×  105 cells/ml in the 
same medium and incubated (30 rain, 37°C, gentle stirring) to allow deacti- 
vation of the glucose transport system of insulin-stimulated cells to near 
basal values before subsequent incubation with glimepiride or insulin. Con- 
troi and desensitized adipocytes  were derived from the same pool of com- 
monly isolated and washed cells,  subjected to an equal number of washes 
so that any losses of cells were identical with the two cell populations.  Sub- 
sequent procedures (photoafl~nity and metabolic labeling, incubation with 
glimepiride and insulin) were performed in parallel for both groups of cells. 
Incubation of  Adipocytes with Insulin and Glimepiride 
Freshly isolated or primary-cultured adipocytes  were incubated (37°C) for 
various periods with the indicated concentrations  of insulin and glimepiride 
in 1 ml of DME medium at 2  x  105 cells/ml in 10-ml scintillation vials 
under very gentle agitation with the cells floating on top of the medium in 
a thin cell layer. Insulin was added from a stock solution made daily by dis- 
solving 0.5 mg insulin in 150 #1 aqua bidest./150 ~tl of 0.1 N HCI and then 
supplementing 200 ttl of twofold KRH buffer lacking glucose; glimepiride 
was added from a 10 mM stock solution prepared daily by suspending 9.95 
nag glimepiride in 1.94 ml aqua bidest., subsequently 60/tl of I N NaOH 
was added and it was warmed up to 50-70°C.  Following  incubation, the 
cells were washed by flotation two times with 5 ml each of HBSS containing 
1 mM sodium pyruvate, 0.2 % BSA, I mM ETDA, 200/~M PMSF, 100/~M 
benzamidine, 20 #g/ml of leupeptin, pepstatin, aprotinin, and antipain and 
finally concentrated fivefold (1  x  106 cells/ml) in the same buffer lacking 
BSA for subsequent analysis of GPl-proteins and preparation of plasma 
membranes. 
Miscellaneous Procedures 
Published procedures were used for immunoblotting of GLUT4 using anti- 
bodies raised in rabbits against rat GLUT4 and ~25I-labeled  anti-rabbit IgG 
from sheep (Towbin et al.,  1979; MOiler and Wied, 1993); determination 
of 2-dcoxyglucose  transport in rat adipocytes  (Foley and Gliemann, 1981; 
M011er and Wied, 1993); isolation (Rodbell,  1964), metabolic labeling with 
myo-[U-14C]inositol  (MOiler et al.,  1994b),  photoaflinity labeling with 
8-N3-[32p]cAMP (Pomerantz et al., 1975; MOiler and Bandlow, 1991), and 
subcellular fractionation of rat adipocytes  (MOiler et al., 1994a); centrifu- 
gation of plasma membranes through a cushion of sucrose (MOiler, G., 
E.-M. Wetekam, C. Jung, and W. Bandlow, manuscript submitted for publi- 
cation); purification of Gcel by affinity chromatography on Nt-(2-amino  - 
ethyl)cAMP-Sepharose  (MOiler et al.,  1992,  1993); immunoprecipitation 
of LPL using a polyclonal rabbit antiserum raised against human milk LPL 
and protein A-Sepharose (MOiler et al., 1993); Triton X-114 (TX-114) parti- 
tioning (Bordier,  1981); TLC analysis (MOiler et al., 1994b); protein deter- 
mination (FoPOv et al.,  1975);  SDS-PAGE and fluorography  using AM- 
PLIFY (MOiler and Zimmermann, 1987). 
Results 
Hydrophilic Membrane-associated Versions of 
Gcel and LPL Are Generated in Response to Insulin 
and Glimepiride 
We first examined whether incubation of isolated rat adipo- 
cytes with glucose, insulin or glimepiride, a representative 
of  the sulfonylurea drugs, for which glucose transport stimu- 
lation  in  insulin-sensitive cells  in  vitro  has  been  amply 
documented (Jacobs et al., 1987; Rogers et al., 1987; Farese 
et al.,  1991), causes conversion of amphiphilic LPL and 
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in response to insulin and glimepiride. Adipocytes were metaboli- 
cally labeled with myo-[14C]inositol  and subsequently incubated 
with 10 #M glimepiride or 10 nM insulin for the periods indicated. 
Plasma membranes were prepared and subjected to TX-ll4 parti- 
tioning (top and bottom) or centrifugation through a sucrose cush- 
ion in the presence of 0.5 M NaC1 (middle). Gcel and LPL were 
purified by affinity-chromatography or immunoprecipitation,  re- 
spectively, from the detergent (d) and aqueous (a) phases or from 
the pellet (p) and supernatant fractions (s) and then analyzed by 
SDS-PAGE and fluorography. Molecular masses indicated on the 
right margin were derived from marker proteins run in parallel. 
Gcel into their hydrophilic forms. Adipocytes were metabol- 
ically labeled with myo-[14C]inositol, then incubated with 
insulin or glimepiride in the presence of glucose, and subse- 
quently  subjected  to  amphiphilic/hydrophilic  partitioning 
using TX-114 or to centrifugation through a sucrose cushion. 
LPL was purified by immunoprecipitation with monospe- 
cific antiserum and Gcel by cAMP-affinity chromatography. 
The fluorogram of the SDS-PAGE (Fig.  1, top and bottom) 
shows  that both,  insulin  and  glimepiride,  caused  a  time- 
dependent conversion of amphiphilic LPL and Gcel (parti- 
tioning into the detergent phase; Fig.  1, lanes 1 and 8) into 
the hydrophilic forms (partitioning into the aqueous phase; 
lanes 2-Tand 9-13). Significant amounts of  hydrophilic Gcel 
and LPL were detectable already 2 and 5 min after the addi- 
tion of insulin or glimepiride, respectively (Fig.  1, lanes 3 
and  9).  After  15  or 30 min,  respectively, the amount of 
hydrophilic GPI-proteins reached a maximum (Fig.  1, lanes 
6 and 12) accounting for up to 35 % (Gcel) and 25 % (LPL) 
of  the total amount of  amphiphilic GPI-proteins in nonstimu- 
lated cells (compare with lanes  1  and 8).  Thereafter, the 
amount of hydrophilic GPI-proteins declined again which 
was  more  obvious  for  insulin  (lane  7)  than  glimepiride 
(lane 13). 
Since the hydrophilic forms of LPL and Gcel were recov- 
ered  from  isolated  plasma  membranes  of  insulin-  and 
glimepiride-stimulated cells we next studied the nature of 
their membrane association. Fig.  1 (middle)  reveals that in- 
cubation with 0.5  M  NaC1  and  subsequent centrifugation 
through sucrose of  plasma membranes isolated from insulin- 
and  glimepiride-treated  cells  led  to  almost  quantitative 
recovery  of LPL and Gcel in the supernatant fraction (shown 
only for Gcel). Omission of the salt prevented the dissocia- 
tion from the membrane indicating bipolar interactions as 
found recently after incubation of rat adipocytes with bac- 
terial PI-PLC (Miiller, G.,  E.-M.  Wetekam, C. Jung,  and 
W. Bandlow, manuscript submitted for publication). The ki- 
netics and efficiency of the insulin- and glimepiride-induced 
membrane release and amphiphilic to hydrophilic conver- 
sion were very similar (Fig. 1, lanes 2-7 and 9-13, compare 
top and middle).  These data indicate that short term treat- 
ment of rat adipocytes with insulin and glimepiride stimu- 
lates cleavage of the GPI membrane anchors of LPL and 
Gcel as has been described for 3T3 adipocytes, but in con- 
trast, does not cause dissociation from the membrane of the 
cleaved versions due to bipolar interactions with the cell 
surface. 
Recent experimental evidences suggest that some lipolyti- 
cally cleaved GPI-proteins are recognized by a receptor of 
hepatocyte and  adipocyte plasma  membranes  (Ishihara  et 
al.,  1987; G. Miiller, unpublished observations). The PLC- 
cleaved proteins can be released from isolated membranes 
by  incubation with  certain  sugar  constituents of the  GPI 
structure like inositol-(cyclic)monophosphate. Consequently, 
we studied whether this type of interaction also applied to 
the hydrophilic forms of LPL and  Gcel  generated in  re- 
sponse to insulin or glimepiride. Adipocytes, metabolically 
labeled with myo-[14C]inositol,  were incubated with 10 nM 
insulin or 10 #M glimepiride. Isolated plasma membranes 
were incubated with increasing concentrations of sugar com- 
pound and then spun through a cushion of sucrose. The pellet 
fractions were subjected to TX-ll4 partitioning. The aque- 
ous phases and supernatant fractions were used for purifica- 
tion and SDS-PAGE of Gcel and LPL. The amounts of hydro- 
philic membrane-associated or soluble Gcel and LPL were 
determined  by  liquid  scintillation  counting  of the  corre- 
sponding excised gel regions. Fig. 2 shows that the amount 
of membrane-associated hydrophilic Gcel (a) and LPL (b) 
decreased  with  increasing  concentrations  of  inositol- 
1,2-cyclic phosphate, inositol-l-monophosphate and glucos- 
amine but was not significantly affected by mannose. Simul- 
taneously, the amount of the hydrophilic forms increased in 
the supernatant fractions (data not shown).  85-90 % of the 
total hydrophilic Gcel and LPL generated in response to ei- 
ther insulin or glimepiride could be displaced as a  maxi- 
mum. As expected, the ICs0 values of the sugar compounds 
were very similar for displacement of the GPI-proteins from 
insulin-  and  glimepiride-treated  cells,  inositol-l,2-cyclic 
monophosphate being most effective. But Gcel was gener- 
ally released with lower concentrations of the sugar com- 
pounds  (ICs0 values;  inositol-l,2-cyclic phosphate:  90-110 
#M;  inositol-monophosphate: 200-220 #M;  glucosamine: 
1.0-1.5  mM)  than  LPL  (ICs0 values;  inositol-l,2-cyclic 
phosphate 400-500 #M; inositol-monophosphate: 750-900 
#M; glucosamine: 3-5 mM). These findings suggest that the 
major fraction of  both Gcel and LPL converted from the am- 
phiphilic into their hydrophilic forms in response to insulin 
and glimepiride was retained at the adipocyte cell surface via 
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Figure 2.  Dissociation  from 
the membrane of lipolytically 
cleaved LPL and  Creel with 
sugar compounds. Adipoeytes 
were  metabolically  labeled 
with  myo-p4C]inositol  and 
subsequently  incubated  (30 
min,  37°C) with  insulin  (10 
nM) or glimepiride (10 ~tM). 
Plasma membranes were pre- 
pared,  incubated  (15  min, 
40C) in the absence or pres- 
ence of the indicated concen- 
trations  of inositol-l,2-cyclic 
monophosphate (&), inositol- 
1-monophosphate  (+),  glu- 
cosamine  (e),  and  mannose 
(.)  and  then  centrifuged 
through a cushion of sucrose. 
The plasma membranes recov- 
ered in the pellet were subjected 
to TX-114  partitioning. Hydro- 
philic Creel (a)  and LPL (b) 
were purified from the aque- 
ous phase by affinity purifica- 
tion or immunoprecipitation, 
respectively. All samples were 
separated by SDS-PAGE  and fluorography. The excised gel regions containing membrane-associated hydrophilic LPL and Gcel were mea- 
sured for radioactivity. The amounts of radiolabeled total hydrophilic LPL or Gcel determined prior to centrifugation were as follows: 
Gcel (+ insulin), 4951 dpm; Gcel (+ glimepiride), 2031 dpm; LPL (+ insulin) 2265 dpm; LPL (+ glimepiride), 941 dpm. 
binding to similar or identical plasma membrane receptors 
which mainly recognize the terminal inositol-(cyclic)mono- 
phosphate epitope and, possibly, the glucosamine moiety of 
the residual GPI anchor structures. 
further experimental support.  The failure to detect inosi- 
tol-l,2-cyclic phosphate and the appearance of inositol after 
deamination may be due to either intrinsic phosphodiester- 
ase and phosphatase activities in the adipocyte plasma mem- 
The GPI-anchors of Gcel and LPL Are 
Cleaved by a Phospholipase in Response to Insulin 
and GUmepiride 
The retention of myo-[14C]inositol  radiolabel in the hydro- 
philic and soluble versions of LPL and Gcel is compatible 
with the action of a phospholipase which is controlled by in- 
sulin and glimepiride. To confirm this and to gain a first in- 
sight into its cleavage specificity, we analyzed the cleavage 
site.  Adipocytes were labeled with  p4C]inositol  and  then 
stimulated with insulin (10 riM) or glimepiride (10/~M) for 
30 rain. Hydrophilic LPL and Gcel were purified from iso- 
lated plasma membranes and then subjected to acid hydroly- 
sis or nitrous deamination. Fig. 3  shows the TLC analysis 
and fluorography of the degradation products. After acid hy- 
drolysis most of the  radiolabel of the  GPI-proteins from 
insulin- and glimepiride-treated adipocytes was recovered as 
inositol  (Fig.  3,  lanes  1  and  4)  excluding  insulin-  and 
glimepiride-induced conversion of myo-inositol into other 
sugar  components.  Nitrous  acid  deamination  generated 
about equal amounts of radiolabeled inositol-phosphate and 
inositol  from both  GPI-proteins  after  insulin  as  well  as 
glimepiride stimulation (Fig. 3, lanes 2 and 5). The inosi- 
tol-phosphate  was  hydrolyzed to  inositol  by  subsequent 
treatment with HC1 (Fig. 3, lanes 3 and 6) proving its iden- 
tity.  The  identification  of inositol-monophosphate  in  the 
TLC patterns provides the first evidence for cleavage of the 
GPI  anchors  by  an  insulin-  and  glimepiride-activated 
GPI-PLC, but definite proof for this specificity will require 
Figure 3. TLC analysis of the 
GPI anchor of hydrophillc  LPL 
and  Gcel.  Adipocy~s  were 
metabolically  labeled  with 
myo-[~4C]inositol and  subse- 
quently  incubated  (30  rain, 
37°C) with 10 nM insulin (Ins) 
or 10 ttM glimepiride (Gli). 
Plasma membranes were pre- 
pared and subjected to TX-114 
partitioning. Hydrophih'c  Gcel 
and LPL were purified from 
the aqueous phase by affinity 
chromatography or immuno- 
precipitation,  respectively, 
and then subjected to nitrous 
acid deamination (n.a.) or left 
untreated. The untreated and 
one  half of the  deaminated 
samples were hydrolyzed with 
HCI (a. h.), the other half was 
left  untreated.  All  samples 
were  analyzed  by  TLC  and 
fluorograpby.  The positions of 
radiolabeled  markers,  inosi- 
tol-l-monophosphate  (  IP  ) , 
myo-inositol (I) and phospha- 
tidylinositol (PI), run in paral- 
lel, are indicated on the right 
margin (Ma). 
The Journal  of Cell Biology,  Volume 126, 1994  1270 A  2280 
2000 
1760 
1800 
1280 
t000 
780 
800 
280 
o 
t~  18oo 
~  126o 
~  IOOO 
78o 
6oo 
26o 
o 
'ni"n 
6  10  111  20  28  30  38  40  48  50  88  60 
GIImeplrlde 
8  10  18  20  28  30  38  40  48  50  68  60 
Incubation Time [mini 
1280' 
,  ,mr ....................... 
0,1  10 
Inlulln InM] 1 
1000 ' 
rSO ' 
800' 
¢:  280' 
£ 
o 
~  12oo • 
o 
"~  IOOO. 
400 " 
200" 
B  2000, 
1780, 
1800, 
/r  .................  ,  ....  , .... 
0.1  1  10 
GIImepir kle  [I.IMI 
Figure  4.  Immunoprecipita- 
tion of hydrophilic Geel with 
anti-CRD  antibodies.  Adi- 
poeytes  were  photoaffinity- 
labeled with 8-Nr[32p]cAMP 
and then incubated in the ab- 
sence or presence of 10 nM 
insulin or 10 #M glimepiride 
for the periods indicated (A) 
or in the absence or presence 
of various  concentrations  of 
insulin and glimepidde for 20 
min (B). The incubation was 
terminated by the addition of 
TX-114 (2%  final concentra- 
tion)  and  phase  separation. 
Hydrophilic  Gcel  was  puri- 
fied from the aqueous phase 
by  affinity  chromatography. 
Subsequently, one half of the 
samples was subjected  to quan- 
titative  immunoprecipitation 
using antiq2RD antibodies (a), 
the other half was left (e). To- 
tal  and  immunoprecipitated 
samples were analyzed by SDS-PAGE  and autoradiography or fluorography, respectively. The radioactivity (dpm values) contained in the 
gel region corresponding to 62 kD (G-eel)  was determined by a Berthold radioactivity scanner and calculated for each time point or concen- 
tration as the difference between radioactivity measured for incubation with insulin or glimepiride or without additions (basal). The values 
represent the means of six determinations using two different cell preparations (n =  12,  +SD). 
brahe or to an enzymic mechanism of the putative adipoeyte 
GPI-PL which differs from that of  bacterial PI-PLCs (Lewis 
et al.,  1993).  Furthermore,  GPI-PLD activity associated 
with adipoeyte plasma membranes which may be due to an 
endogenous enzyme or originate from the serum cannot be 
excluded. The existence of  a GPI-PLD in mammalian serum 
and tissues has well been documented (Cardoso de Almeida 
et al.,  1988;  Low and Prasad,  1988;  Davitz et al.,  1989; 
Hoener et al.,  1990; Huang et al.,  1990). 
To gain information about the physiological significance of 
the adipoeyte GPI-PL, we studied the time course and con- 
centration dependence of the stimulation of this enzyme by 
insulin and glimepiride. For this, the hydrophilic Gcel was 
purified from the aqueous phase after TX-114 partitioning of 
total lysates from adipocytes which had been photoaflinity 
labeled with 8-Nr[32p]cAMP and then incubated with in- 
sulin or glimepiride. To assay for the cleavage of the GPI an- 
thor, half of the hydrophilic Gcel was tested for anti-cross- 
reacting determinant (CRD) immunoreactivity by subsequent 
immunoprecipitation with anti-CRD antibodies. These anti- 
bodies exclusively recognize determinants in the (glycosyl)- 
phosphatidylinositol-specific phospholipase [(G) PI-PLC]- 
cleaved anchors and do not cross-react with protein epitopes 
(Cardoso de Almeida et al., 1988; Zamze et al., 1988). Fig. 
4 shows that there is a difference between the amounts of to- 
tal and immunoprecipitated hydrophilic [32P]cAMP-labeled 
Gcel purified from insulin- or glimepiride-stimulated and 
nonsfimulated adipocytes. From the time course (Fig. 4 a) 
it can be seen that the amount of total hydrophilic form in- 
creased up to 45 min for insulin (upper half) and glimepiride 
stimulation (lower half), followed by a plateau for the next 
15-60 rain (not shown). However, at each time point anti- 
CRD antibodies recognized only a fraction of the total hydro- 
Table I.  Generation of Hydrophilic Gcel Lacking the 
Anti-CRD Epitope in Response to Insulin or Glimepiride 
Gcel  lacking anti-CRD epitope 
Incubation Time  Total Amount  Fraction 
rain  arb. units  % total 
Insulin 
Glimepiride 
1  1.86  47.8 
2  2.22  57.1 
5  4.36  56.1 
10  5.33  46.6 
20  6.79  42.1 
30  8.09  44.2 
45  10.37  51.8 
60  13.11  62.0 
1  0.67  46.2 
2  1.64  55.0 
5  2.42  50.1 
10  2.78  40.7 
20  3.95  40.8 
30  5.15  43.2 
45  7.41  54.7 
60  8.38  61.8 
The dpm values measured for total and anti-CRD immunoreactive hydrophilic 
[riP]cAMP  photmtfinity-labeled  Gcel were derived from Fig. 7 a. The amount 
of hydrophilic G-cel lacking anti-CRD epitope was calculated as the difference 
between hydrophilic total and anti-CRD immunoreactive  protein (arb. units) and 
expressed as fraction of the hydrophilic total protein at each time point (set at 
100%; Fig. 7 b). 
philic Gcel which declined after 30 min.  Thus, a consid- 
erable fraction of  the hydrophilic form of  the GPI-protein did 
not harbor the major epitope, the terminal inositol-(cyclic)- 
monophosphate residue. Gcel protein lacking this epitope 
accumulated during the incubation resulting in a drastic in- 
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LPL and Gcel in response to 
insulin and glimepiride in nor- 
mal  and  desensitized  adipo- 
cytes. Adipocytes were incu- 
bated (20 h, 37°C) in primary 
culture in the presence of 0.5 
mM  glucose (normal) or 20 
mM glucose plus 16 mM glu- 
tamine  plus  10  nM  insulin 
(desensitized).  Subsequently, 
the washed cells were meta- 
bolically  labeled  with  myo- 
[14C]inositol and  then  incu- 
bated  (30  min,  37°C) with 
various concentrations of in- 
sulin or glimepiride. Plasma membranes were prepared and subjected to TX-114 partitioning. Hydrophilic Gcel (62 kD) and LPL (60 
kD) were purified from the aqueous phase by affinity chromatography (a) or immunoprecipitation (b), respectively. All samples were ana- 
lyzed by SDS-PAGE and fluorography. The molecular masses were derived from marker proteins run in parallel. 
crease of its total amount with time (Table I). The ratio with 
regard to total hydrophilic protein increased only at later in- 
cubation times. This time course is compatible with the ob- 
served reduction of the amount of hydrophilic myo-['4C]in  - 
ositol-labeled LPL and Gcel after 15 min of stimulation by 
insulin and 30 rain by glimepiride (see Fig.  1). But, these 
data suggest that, in addition to the lipolytic cleavage, a sec- 
ond hydrolytic processing event occurs within the GPI struc- 
ture of certain GPI-proteins in consequence of an incubation 
of rat adipocytes with insulin or glimepiride and removes the 
epitope(s) recognized by the anti-CRD antiserum. From the 
concentration dependence of short term stimulation (20 min) 
(Fig. 4 b) of the PL activity (reflected by the amount of hy- 
drophilic anti-CRD immunoreactive Gcel) and of the addi- 
tional hydrolytic activity (reflected by the difference  between 
total and anti-CRD immunoreactive hydrophilic protein), we 
calculated for insulin a maximal effect at 10 nM for both ac- 
tivities and  EDso values of 1.2  and 2.1  nM,  respectively, 
and  for glimepiride a  maximal effect at  10 #M  and EDs0 
values of 1.7 and 2.5 #M, respectively. Thus, the concentra- 
tions of insulin and glimepiride required for stimulation of 
the PL and the second hydrolytic activity are very similar. 
These observations are compatible with the possibility that 
the lipolytic cleavage reaction is rate limiting for the subse- 
quent hydrolytic processing but do not exclude two indepen- 
dent  processing  mechanisms  with  similar  dose  response 
characteristics. The effective concentrations of insulin and 
glimepiride lie in the range necessary for glucose transport 
stimulation  by  insulin  and  glimepiride  in  rat  adipocytes 
(Muller and Wied,  1993). This correlation provides a first 
hint that glucose transport is required for activation of the 
GPI-PL. 
Impairment of Glucose Transport Interferes with 
Activation of the GPI-PL 
To gain  further evidence for this  conclusion we used  rat 
adipocytes which exhibited an impaired responsiveness and 
sensitivity of glucose transport stimulation by insulin but not 
by glimepiride. Adipocytes were incubated with high con- 
centrations of insulin,  glucose,  and glutamine in primary 
culture which causes desensitization of the glucose transport 
system towards insulin but not glimepiride. This is reflected 
by a 50 % reduction of the maximal insulin-stimulated glu- 
cose transport velocity and a  rightward shift of the dose- 
response curve of insulin from an EDs0 of 0.45 nM to 1.85 
nM, whereas the maximal glimepiride response and glimep- 
iride dose-response curve hardly were affected (Miiller and 
Wied, 1993). The response of the PL to insulin and glimepi- 
ride was studied in desensitized cells after metabolic labeling 
with  myo-[14C]inositol.  The  fluorograms  after  the  SDS- 
PAGE of LPL (Fig. 5 a) and Gcel (b), lipolytically cleaved 
under these conditions, show that the amounts of the hydro- 
philic forms recovered at each insulin concentration (upper 
halves) was considerably lower in desensitized (lanes 9-14) 
versus normal adipocytes (lanes 2-7). This resulted in a re- 
duced maximal responsiveness (15-25 % for LPL, 30-35 % 
for Gcel) and sensitivity (rightward shift of the correspond- 
ing dose response curves; desensitized: EDso =  7.5 nM for 
LPL, 4.7 nM for Gcel; normal: EDs0 =  2.2 nM for LPL, 
1.7 nM for Gcel) of the PL toward stimulation by insulin. In 
contrast, its maximal responsiveness and sensitivity toward 
stimulation by glimepiride (lower halves) remained largely 
unaffected (Fig. 5, lanes 9-14). The same behavior holds for 
glucose transport: the activation by insulin is reduced (data 
Table If. Inhibition of Glucose Transport in Rat Adipocytes 
Inhibitor 
Stimulation  Control  Cytochalasin B  Phloretin  Polymyxin B 
Basal  254  +  66  223  +  81  308  +  56  198  +  38 
Insulin  3891  +  431  487  +  78  571  +  102  389  +  61 
Glimepiride  1623  +  210  305  +  55  413  +  71  255  +  41 
Adipocytes were incubated (15 min, 37°C) in the absence (Control) or presence 
of 20 #M cytochalasin B, 0.3 mM phloretin, or 0.5 mg/mi polymyxin B and 
then supplemented with insulin (10 nM final concentration) or glimepiride (10 
p.M final concentration), or left untreated. After further incubation (30 win), 
1 #Ci of v-2-[3H]deoxygincose  (0.1 mM final concentration) was added. The 
uptake reaction (10 rain, 25°C) was terminated by addition of cytochalasin B 
(50 #M final concentration) to all samples and rapid centrifugation of the incu- 
bation mixture through dinonylphtalate. The cells were recovered from the oil 
layer and counted for radioactivity.  Each dpm value is corrected for diffusion 
into cells and entrapping in extracellular spaces of [3H]deoxygincose  by sub- 
tracting the value measured for con'esponding  incubation mixtures  in the presence 
of 0.1  mM L-[3H]deoxyglucose  (identical  specific  radioactivity).  The values 
represent the means of eight determinations from two different cell preparations 
each (n  =  16,  +SD). 
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translocation by polymyxin B. Adipocytes were incubated (20 h, 
37°C) in primary culture in the presence of 0.5 mM glucose (nor- 
real) or 20 mM glucose plus 16 mM glutamine plus 10 nM insulin 
(desensitized). Subsequently, the adipocytes were preincubated (20 
min) without (Control) or with 0.5 mg/ml polymyxin B and then 
incubated in the absence or presence of 10 nM insulin (Ins) or 10 
/~M glimepiride (Gli). Plasma membranes (PM) and low density 
microsomes (LDM) were prepared,  separated by SDS-PAGE and 
analyzed for the presence of GLUT4 by immunoblotting. The auto- 
radiogram of a typical blot is shown. The molecular masses are de- 
rived from marker proteins run in parallel. 
not shown here; see Miiller and Wied, 1993), whereas stim- 
ulation by glimepiride is unchanged. Thus desensitization of 
the glucose transport system in rat adipocytes is accompa- 
nied by decreased activation ofa GPI-PL or, in other words, 
the activity states of the glucose transport system and the PL 
seem to  correlate.  Moreover,  this  correlation can  be  ex- 
tended to the translocation of GLUT4 from tubulovesicular 
structures of the trans-Golgi network (which fractionate as 
low  density  microsomes  [LDM])  to  plasma  membranes. 
GLUT4 translocation represents the molecular basis for the 
increase  of  glucose  transport  by  insulin  or  glimepiride 
(Cushman  and  Wardzala,  1980;  Suzuki  and  Kono,  1980; 
James et al., 1989; Slot et al., 1991; Miiller and Wied, 1993) 
and is impaired in desensitized adipocytes toward stimula- 
tion by insulin but not glimepiride (see below, Fig.  6). 
Next, we tested the effect of inhibitors of glucose transport 
on the activation of the GPI-PL. Table II shows that 20 #M 
cytochalasin B, 0.3 mM phloretin or 0.5 mg/ml polymyxin 
B completely inhibited the insulin- and glimepiride-stimu- 
lated glucose transport in rat adipocytes. Cytochalasin B and 
phloretin bind directly to GLUTI and GLUT4 (for a review 
see Gould and Holman, 1993), thereby interfering with the 
facilitated diffusion of glucose. Polymyxin B inhibits insulin 
stimulation  of glucose  transport  by blocking  the  insulin- 
induced translocation of GLUT4 (Cormont et al.,  1992). 
This was demonstrated by successive incubation of normal 
and desensitized adipocytes with polymyxin B and insulin 
and subsequent fractionation into LDM and plasma mem- 
branes which were assayed for GLUT4 by immunoblotting. 
The autoradiogram of the blot (Fig. 6) shows that in normal 
adipocytes insulin (lanes 2) and, to a lesser degree, glimepi- 
ride (lanes 3) caused a decrease of immunoreactive GLUT4 
(43 kD) in LDM and a corresponding increase in the plasma 
membrane reflecting translocation of GLUT4 from LDM to 
the plasma membrane. Preincubation of normal adipocytes 
with polymyxin B  or desensitization of adipocytes dimin- 
ished insulin-induced GLUT4 translocation to 15-10% (Fig. 
6, lane 5, top) or 50--40% (lane 8, top), respectively. Despite 
this block in translocation, incubation with polymyxin B led 
to a significant decline of GLUT4 in LDM (Fig. 6, lane 5, 
bottom). This is in contrast to desensitized cells (lane 8, bot- 
tom)  and  may  be  caused  by  targeting  of  LDM  to  an 
unidentified intracellular storage compartment or by inhibi- 
tion of fusion of LDM with the plasma membrane. Similar 
observations have been reported previously by others (Cor- 
mont et al.,  1992).  In desensitized adipocytes glimepiride 
caused 65-70% translocation of GLUT4 to the plasma mem- 
brane (Fig. 6, lanes 9) compared to normal cells (lanes 6). 
This translocation was reduced by polymyxin B to 25-15% 
despite significant loss of GLUT4 from LDM (Fig. 6, lanes 
6 and  12). 
Amphiphilic and hydrophilic LPL and Gcel were purified 
from plasma  membranes  of adipocytes,  which  had  been 
metabolically labeled  with myo-[~4C]inositol  and  then in- 
cubated with the respective inhibitor followed by exposure 
to insulin (Fig. 7 a) or glimepiride (b). The analysis by SDS- 
PAGE and fluorography shows that cytochalasin B, phloretin 
and polymyxin  B (data not shown) did not affect the distribu- 
tion between the amphiphilic and hydrophilic versions of the 
two GPI-proteins in nonstimulated control cells (Fig.  7 a, 
Figure 7. Effect of glucose transport inhibi- 
tors on the lipolytic  cleavage of LPL and 
Gcel. Adipocytes were metabolically labeled 
with myo-[t4C]inositol and subsequently in- 
cubated (20 min, 37°C) in the absence or pres- 
ence of 20/zM cytochalasin B (Cyt.B), 0.3 
mM  phloretin  or 0.5  mg/ml  polymyxin B 
(Poly.B). The incubation was continued (30 
min) without (Control) or with 10 nM insulin 
(a) or 10 #M glimepiride (b). Plasma mem- 
branes were prepared and subjected to TX- 
114 partitioning. Hydrophilic Gcel and LPL 
were purified from the aqueous (a) and deter- 
gent (d) phases by affinity purification or im- 
munoprecipitation, respectively. All samples 
were analyzed by SDS-PAGE and fluorogra- 
phy. Molecular  masses were  derived  from 
marker proteins run in parallel. 
Miiller et al. Signal Transduction in Rat Adipocytes  1273 Figure 8. Effect  of 2-deoxyglucose  on the lipolytic cleavage  of LPL 
and  G-eel. Adi~es  were  metabolically  labeled with  myo- 
['4C]inositol, washed and then incubated (60 rain, 37"C) with 5 
mM sodium pyruvate in DME medium lacking glucose. One half 
of the cells was incubated (20 rain) with 0.5 mg/ml polymyxin B, 
the other half was left untreated. Subsequently,  aliquots of the ceils 
were incubated (5 min, 37"C) in the absence (Control, lanes I and 
2) or presence of 2 mM glucose (lanes 3-6) or 2-deoxyglucose 
(lanes 7-10) and then supplemented  with glirnepiride (10 #M final 
concentration, shown only for Gce/) or insulin (10 nM final  con- 
centration). After further incubation (30 min), plasma membranes 
were prepared and subjected to TX-114 partitioning. Gcel and LPL 
were purified and analyzed as in Fig. 7. 
lanes 1-6).  In contrast, each of the three inhibitors almost 
completely blocked the activation of the PL by insulin (Fig. 
7 a, lanes 9--14, compare with lanes 7and 8) and glimepiride 
(b, lanes 1-6, compare with lanes 7and 8). These data dem- 
onstrate that stimulation of glucose transport is required for 
activation of the GPI-PL in rat adipocytes. 
Transport of  Deoxyglucose into Rat Adipocytes 
Supports the Acavation of the GPI-PL 
Finally we asked the question whether metabolism of glu- 
cose is required for activation of the GPI-PL. For this, the 
amphiphilic to hydrophilic conversion of LPL and Gcel was 
monitored in adipocytes which had been metabolically la- 
beled  with  myo-["C]inositol  in  glucose-free  pyruvate- 
containing medium and  then incubated with glimepiride 
(Gcel)  or insulin in the presence of glucose or the non- 
metabolizable  glucose  analogue,  2-deoxyglucose.  The 
fluorography of the SDS-PAGE  (Fig.  8) of the amphiphilic 
and hydrophilic GPI-proteins shows that in the absence of 
glucose (and presence of sodium pyruvate) both, insulin and 
glimepiride, failed to support lipolytic cleavage of LPL and 
Gcel (lane 2). Supplementation of glucose restored the acti- 
vation of the GPI-PL by both agents (Fig. 8, lane 4) which 
was blocked (to 10-15 % for Gcel and 25-35 % for LPL) by 
polymyxin  B (lane 6). Interestingly, addition of 2-deoxyglu- 
cose instead of glucose to the washed adipocytes resulted in 
stimulation of the  lipolytic cleavage by both  insulin and 
glimepiride  to  60-75%  observed  for  the  corresponding 
values with glucose (Fig. 8, compare lanes 8 and 4). Again, 
the GPI-PL was hardly activated when polymyxin B was 
also present (Fig. 8, lane 10). These results confirm that in- 
creased glucose flux into adipocytes is prerequisite for stim- 
ulation of the GPI-PL and furthermore suggest that glucose 
metabolism beyond the  phosphorylation step  is  not nec- 
essary. 
Discussion 
A  functional role of GPI anchorage of LPL and Gcel  in 
insulin-sensitive cells,  such as isolated or cultured adipo- 
cytes, may rely on their accessibility to specific cleavage by 
an insulin-inducible GPI-PL: short term incubation of rat 
adipocytes with physiological concentrations of insulin or 
with  the  sulfonylurea,  glimepiride,  causes  the  lipolytic 
cleavage of their GPI anchors as revealed by the retention of 
the myo-inositol radiolabel and anti-CRD cross-reactivity. 
This suggests stimulation of a GPI-PL by insulin or glimepi- 
ride. Since action of a GPI-PLD would destroy the epitope 
recognized by anti-CRD antibodies and since phosphate is 
apparently  retained  with  the  inositol  after  cleavage,  the 
insulin-activated PL is presumably of type C. 
Lipolytic cleavage  of the GPI anchor and membrane re- 
lease of LPL may be physiologically related to the dramatic 
shift of LPL activity from adipose to muscle tissue observed 
during certain nutritional situations in man (for a review see 
Smith and Pownall, 1984). In contrast, the physiological role 
for the analogous lipolytic processing of Gcel remains un- 
clear so far. We were unable to detect cAMP-dependent pro- 
tein kinase A activity in solubilized plasma membranes from 
untreated  and  insulin-  or  glimepiride-treated  adipocytes 
using  the  typical  protein  kinase  A  substrate  Kemptide 
(Miiller, G., unpublished data). This argues against partici- 
pation of anchor cleavage in promoting cAMP-dependent ki- 
nase activation of  the membrane-associated or released Gcel 
protein. Such an activation of a cryptic protein kinase A ac- 
tivity upon lipolytic cleavage of a lipidic membrane anchor 
has been suggested for a mitochondrial cAMP-binding pro- 
tein in yeast (Miiller and Bandlow, 1989). 
It may be of functional significance, that after incubation 
of rat adipocytes with insulin or glimepiride we observed a 
time-dependent loss of inositol-phosphate from the lipolyti- 
cally cleaved GPI anchor of hydrophilic Gcel. This may be 
taken as evidence for a secondary hydrolytic  processing step 
within the residual GPI structure or near the carboxyl termi- 
nus of  the GPI-protein. Apparently, this reaction exceeds the 
cleavage rate of the insulin- or glimepiride-stimulated phos- 
pholipase after about 20-30 min of incubation resulting in 
a decline of the steady state concentration of ['4C]inositol- 
labeled and anti-CRD immunoreactive Gcel protein despite 
continuous constant lipolytic cleavage.  Similar observations 
have been made with GPI-proteins released from 3T3 adipo- 
cytes in response to insulin and glimepiride (Miiller et al., 
1993) as well as with the corresponding Gcel protein from 
Saccharomyces cerevisiae after  glucose-induced  lipolytic 
cleavage of its GPI anchor. 
Loss of  the inositol residue caused by a secondary process- 
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terminus  of the GPI-protein)  should result in the en bloc 
removal  of  phosphoinositolglycan  fragments  from  GPI 
membrane  anchors  which  may  function  in  insulin,  sul- 
fonylurea and nutritional  signaling.  Cleavage products gen- 
erated by the insulin-stimulated  metabolism of GPI anchors 
have been speculated to act as soluble mediators of certain 
insulin effects (Lamer, 1988). Experimental support for this 
possibility originated from experiments,  where insulin-sen- 
sitive  rat hepatocytes and  adipocytes had been incubated 
with the PLC-cleaved GPI anchors isolated from the proteo- 
lytically digested GPI-proteins, human erythrocyte acetyl- 
cholinesterase (Deeg et al., 1993) and trypanosomal soluble 
variant  surface  glycoprotein  (Misek  and  Saltiel,  1992). 
These phosphoinositolglycans,  linked via a phosphoethanol- 
amine bridge to the carboxy-terminal amino acids of acetyl- 
cholinesterase and variant  surface glycoprotein, acted spe- 
cifically  and  mimicked  some of the  insulin  actions  in  a 
concentration-dependent manner. For the second processing 
reaction to occur and/or the subsequent uptake of the result- 
ing putative signaling  molecule(s) into the cell, peripheral 
membrane association of lipolytically cleaved GPI-proteins 
at the cell surface as demonstrated for rat adipocytes in the 
present study and for yeast spheroplasts  previously (Mfiller 
and Bandlow,  1993) may be prerequisite. 
A  participation  of a  GPI-PL in mediating  some of the 
short term insulin effects is further suggested by the present 
observations that (a) GPI-PL activation depends on physio- 
logical  plasma  insulin  levels  and  follows  a  rapid  onset 
(within 2-5 min) characteristic  for the regulation  of key en- 
zymes  of  glucose  and  lipid  metabolism  by  insulin  (b) 
GPI-PL activation  by insulin  is impaired in rat adipoeytes 
which had been desensitized  for glucose transport stimula- 
tion by insulin.  This  desensitization  in  vitro  was accom- 
plished by incubation  with high  concentrations of glucose 
and  insulin  (Marshall  et  al.,  1991) thus  mimicking  the 
hyperinsulinemic  and hyperglycemic situation typical of the 
insulin  resistant state in animal  models of type II diabetes 
and subjects with impaired glucose tolerance.  An impair- 
ment of the insulin  stimulation  of a GPI-PL is a candidate 
mechanism for the postreceptor defect generally found in 
insulin-resistant  states  (Macaulay and  Larkins,  1988).  A 
block in the activation of this enzyme has also been implied 
for: (a) insulin-resistant  hepatocytes isolated from Strepto- 
zotocin-induced diabetic rats since the hydrolysis of free GPI 
lipids  in response to insulin  and the activation  of glycogen 
synthesis by equivalent volumes of hydrolysis products were 
significantly  reduced compared to untreated rats (Sanchez- 
Arias et al., 1992); and (b) for type II diabetic patients since 
the insulin-mimetic  bioactivity and chiro-inositol content of 
a  phosphoinositolglycan  fraction isolated from equivalent 
volumes/amounts  of hemodialysate,  urine and  muscle ho- 
mogenate were markedly reduced compared to those from 
nondiabetic  controls (Asplin  et al.,  1993). 
The following lines of evidence strongly  suggest that in- 
creased glucose transport mediates the stimulatory effects of 
insulin and glimepiride on the GPI-PL in rat adipocytes:  (a) 
cells which have been desensitized  for insulin stimulation  of 
glucose transport,  showed  impaired insulin  stimulation  of 
the GPI-PL with comparable elevations of the EDs0 values 
for both processes. (b) The sulfonylurea  glimepiride stimu- 
lated glucose transport and GPI-PL activity in desensitized 
and normal adipoeytes to about the same extent and within 
the same range  of drug concentration  (to 25-30%  of the 
maximal  insulin response in normal cells). (c) Inhibition of 
the stimulation  of glucose transport was accompanied by an 
almost complete block of activation of the GPI-PL by insulin 
and  glimepiride.  Increased  glucose transport  is based on 
GLUT4 translocation  and leads to elevated glucose flux and 
metabolism  in  the  cell.  The  present  data  allow  to  dis- 
criminate  between these possibilities  for the functional  role 
of glucose transport for activation of the GPI-PL. Glucose- 
free  incubation  medium  does not  interfere  with  GLUT4 
translocation  but did not support insulin  and glimepiride 
stimulation  arguing  against  a  direct  coupling  of GLUT4 
translocation  to  GPI-PL  activation.  3-O-methylglucose 
could not replace D-glucose (G.M., unpublished  observa- 
tions) thus excluding the possibility that glucose flux across 
GLUT4 per se triggers  the activation.  In contrast, 2-deoxy- 
glucose did substitute  for D-glucose.  Thus phosphorylation 
of glucose is necessary and sufficient  for activation  of the 
GPI-PL.  The  latter  data  are  compatible  with  previous 
findings showing that release of LPL from cultured adipo- 
cytes did  not depend on  energy  supply  (Spooner et al., 
1979). 
In conclusion, stimulation  of glucose transport,  which is 
the rate-limiting  step for the generation  of glucose-6-phos- 
phate seems to represent the common molecular mechanism 
which links the activation  of a GPI-PL to the insulin,  sul- 
fonylurea  and glucose signaling  cascades in organisms  as 
divergent as adipocytes and yeast. Thus, in rat adipocytes the 
receptors for insulin (and growth factors) and sulfonylureas 
(Martz et al., 1989) may be coupled to the GPI-PL only in- 
directly via the formation of glucose-6-phosphate.  This situ- 
ation is reminiscent  of the regulation  of gene expression of 
many glycolytic and lipogenic enzymes by insulin  and glu- 
cose in  hepatocytes and  adipocytes.  Insulin  dramatically 
stimulated  the transcription  of the genes for fatty acid syn- 
thase and acetyl-CoA carboxylase in cultured rat adipose 
tissue and adult hepatocytes only when glucose or 2-deoxy- 
glucose were present in the culture medium.  3-O-methyl- 
glucose was ineffective (Foufelle et al., 1992; Fukuda et al., 
1992). On the basis of these experiments,  the existence of a 
nuclear  factor has  been proposed whose activity is  con- 
trolled by the glucose-6-phosphate level in the cell and which 
binds to carbohydrate-responsive  elements of these genes 
and regulates  their  rate of transcription  (for recent reviews 
see Girard et al.,  1994; Vaulont and Kahn,  1993). In anal- 
ogy, it is tempting to speculate about a cytosolic factor which 
binds to glucose-6-phosphate  and  to the GPI-PL thereby 
regulating  its activity. 
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